論文 - 勝野 雅央
-
Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by expanded polyglutamine. 査読有り
Minamiyama M, Katsuno M, Adachi H, Doi H, Kondo N, Iida M, Ishigaki S, Fujioka Y, Matsumoto S, Miyazaki Y, Tanaka F, Kurihara H, Sobue G.
Nat Med. 18 巻 頁： 1531-1538 2012年
-
Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. 査読有り
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F, Sobue G.
Brain 135 巻 頁： 2838-2848 2012年
-
TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals.
Sahashi K, Hua Y, Ling KK, Hung G, Rigo F, Horev G, Katsuno M, Sobue G, Ko CP, Bennett CF, Krainer AR.
Genes Dev. 26 巻 頁： 1874-84 2012年
-
Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy (SBMA). 査読有り
Mano T, Katsuno M, Banno H, Suzuki K, Suga N, Hashizume A, Tanaka F, Sobue G.
Muscle Nerve 46 巻 頁： 692-697 2012年
-
Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. 査読有り
Miyazaki Y, Adachi H, Katsuno M, MInamiyama M, Jiang YM, Huang Z, Doi H, Matsumoto S, Kondo N, Iida M, Tohnai G, Tanaka F, Muramatsu S, Sobue G.
Nat Med. 18 巻 頁： 1136-1141 2012年
-
Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. 査読有り
Ishigaki S, Masuda A, Fujioka Y, Iguchi Y, Katsuno M, Shibata A, Urano F, Sobue G, Ohno K.
Sci Rep. 2 巻 頁： 529 2012年
-
Molecular pathophysiology and disease-Modifying therapies for spinal and bulbar muscular atrophy. 招待有り 査読有り
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G.
Arch Neurol. 69 巻 頁： 436-440 2012年
-
Differential change of clinical outcome measures in spinal and bulbar muscular atrophy: comparison of natural history with placebo-treated group. 査読有り
Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Tanaka F, Sobue G.
J Neurol. 259 巻 頁： 712-719 2012年
-
Perspectives on molecular targeted therapies and clinical trials for neurodegenerative diseases. 招待有り 査読有り
Katsuno M, Tanaka F, Sobue G.
J Neurol Neurosurg Psychiatry 83 巻 頁： 329-335 2012年
-
Transforming growth factor-beta signaling in motor neuron diseases. 招待有り 査読有り
Katsuno M, Adachi H, Banno H, Suzuki K, Tanaka F, Sobue G.
Current Mol Med. 11 巻 頁： 48-56 2011年
-
Macroautophagy Is Regulated by the UPR-Mediator CHOP and Accentuates the Phenotype of SBMA Mice. 査読有り
Yu Z, Wang AM, Adachi H, Katsuno M, Sobue G, Yue Z, Robins DM, Lieberman AP.
PLoS Genet. 7 巻 頁： e1002321 2011年
-
Dutasteride for spinal and bulbar muscular atrophy: another advance towards disease-modifying therapy. 招待有り 査読有り
Banno H, Katsuno M, Suzuki K, Sobue G.
Lancet Neurol. 10 巻 頁： 113-115 2011年
-
The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. 査読有り
Suzuki K, Katsuno M, Banno H, Takeuchi Y, Kawashima M, Suga N, Hashizume A, Hama T, Uchida K, Yamashita F, Nakamura T, Hirayama M, Tanaka F, Sobue G.
J Neurol Neurosurg Psychiatry 81 巻 頁： 567-571 2010年
-
Clinical features and molecular mechanisms of spinal and bulbar muscular atrophy (SBMA). 招待有り 査読有り
Katsuno M, Banno H, Suzuki K, Adachi H, Tanaka F, Sobue G.
Adv Exp Med Biol. 685 巻 頁： 64-74 2010年
-
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. 査読有り
Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G; for the Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group.
Lancet Neurol. 9 巻 頁： 875-884 2010年
-
Disrupted TGF-beta signaling in spinal and bulbar muscular atrophy. 査読有り
Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, Suzuki K, Tanaka F, Sobue G.
J Neurosci. 30 巻 頁： 5702-5712 2010年
-
17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in a SBMA model mouse. 査読有り
Tokui K, Adachi H, Waza M, Katsuno M, Minamiyama M, Doi H, Tanaka K, Hamazaki J, Murata S, Tanaka F, Sobue G.
Hum Mol Genet 18 巻 頁： 898-910 2009年
-
Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA). 招待有り
Suzuki K, Katsuno M, Banno H, Sobue G.
Neuropathology 29 巻 頁： 509-516 2009年
-
Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome. 査読有り
Morozumi S, Kawagashira Y, Iijima M, Koike H, Hattori N, Katsuno M, Tanaka F, Sobue G.
J Neurol Sci. 279 巻 頁： 57-61 2009年
-
Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. 招待有り
Banno H, Katsuno M*, Suzuki K, Tanaka F. Sobue G.
10 巻 頁： 1000-1012 2009年